Registration Dossier

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
7.3 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
24
Dose descriptor starting point:
NOAEL
Value:
100 mg/kg bw/day
Modified dose descriptor starting point:
NOAEC
Value:
176 mg/m³
Explanation for the modification of the dose descriptor starting point:

NOAECinhal(mg/m3)= NOAELoral* 1/sRVrat*ABSoral-rat/ABSinh-human*sRVhuman/wRV

=100*1/0.38*1/1*6.7/10=176 mg/m3

AF for dose response relationship:
1
Justification:
covered by route to route extrapolation
AF for differences in duration of exposure:
2
Justification:
subchronic (90 day study) to chronic; ECHA guidance on Info Requirements R.8, 2012, page 24
AF for interspecies differences (allometric scaling):
4
Justification:
NOAEL oral rat test; ECHA guidance on Info Requirements R.8, 2012, page 24
AF for other interspecies differences:
1
Justification:
covered by route to route extrapolation
AF for intraspecies differences:
3
Justification:
ECETOC TR 110 Guidance on Assessment Factors to Derive a DNEL, October 2010, page 34
AF for the quality of the whole database:
1
Justification:
2 guideline studies (OECD 408 and OECD 414) reported an NOAEL of 100 mg/kg bw/day.
AF for remaining uncertainties:
1
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
4.2 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
24
Dose descriptor starting point:
NOAEL
Value:
100 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
100 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:

From toxicokinetic considerations it is expected that diacetone acrylamide is well absorbed for the oral and less for the dermal route.

Worst case assumption: ABS oral rat/ABS dermal human = 1

AF for dose response relationship:
1
Justification:
covered by route to route extrapolation
AF for differences in duration of exposure:
2
Justification:
subchronic to chronic (ECHA guidance on Info Requirements R.8, 20120
AF for interspecies differences (allometric scaling):
4
Justification:
ECHA guidance on Info Requirements R.8, 2012, page 24
AF for other interspecies differences:
1
Justification:
covered by route to route extrapolation
AF for intraspecies differences:
3
Justification:
ECETOC TR 110 Guidance on Assessment Factors to Derive a DNEL, October 2010, page 34
AF for the quality of the whole database:
1
Justification:
2 guideline studies (OECD 408 and OECD 414) reported an NOAEL of 100 mg/kg bw/day.
AF for remaining uncertainties:
1
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
acute toxicity
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
low hazard (no threshold derived)

Additional information - workers

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population